2 ms·
I wonder if a vaccine for SARS-CoV-2 might trigger the same response from the immune system. With mRNA, vaccines could be much easier to create and could have
by Calvin02 6y ago
I wonder if a vaccine for SARS-CoV-2 might trigger the same response from the immune system.
With mRNA, vaccines could be much easier to create and could have an interesting side effects.
- _ph_ 6y agoBiontech was actually founded to use mRNA "vaccines" to mark tumor cells for your immune system, so that your immune system starts attacking the tumor cells. It was never the plan to produce actual vaccines against viral diseases, but due to their research, they were perfectly positioned to do so, when the pandemic struck.
- KraftKacke 6y agoAFAIK this is somewhat incorrect. Biotech switched to vaccine focus before SARS2 and the reason for the rapid development was the groundwork done for a SARS(1) vaccine. It is also worth noting, the mRNA part wasn't the innovative technology, but the nano lipid vehicle allowing immune evasion and cell fusion. Because of that, the SARS2 pandemic fast tracked the tech for numerous targets and will benefit cancer medicine as well as future vaccine developments.